Sorafenib Alone versus Sorafenib Combined with Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

MatchIt: Nonparametric Preprocessing for Parametric Causal Inference

(2015) Daniel E. Ho et al.   Journal of Statistical Software

Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma

(2012) Joong-Won Park et al.   JOURNAL OF HEPATOLOGY

Sorafenib Dose Escalation in the Treatment of Advanced Hepatocellular Carcinoma

(2012) Jeong Eun Kim et al.   ONCOLOGY

Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib

(2012) Matthias Pinter et al.   RADIOLOGY

Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma

(2011) Julien Edeline et al.   CANCER

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

TACE and Sorafenib: A Good Marriage?

(2011) Ghassan K. Abou-Alfa   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma

(2011) Timothy M. Pawlik et al.   JOURNAL OF CLINICAL ONCOLOGY

Transarterial Chemoembolization Can Be Safely Performed in Patients with Hepatocellular Carcinoma Invading the Main Portal Vein and May Improve the Overall Survival

(2011) Goh Eun Chung et al.   RADIOLOGY

Which Response Criteria Best Help Predict Survival of Patients with Hepatocellular Carcinoma Following Chemoembolization? A Validation Study of Old and New Models

(2011) Ju Hyun Shim et al.   RADIOLOGY

Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study

(2010) Jun Luo et al.   ANNALS OF SURGICAL ONCOLOGY

Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: Does transarterial chemoembolization improve survival in these patients?

(2010) Dong-Jun Yoo et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

(2010) Riccardo Lencioni et al.   SEMINARS IN LIVER DISEASE

Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

(2009) Johannes Lammer et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion

(2009) Kang Mo Kim et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Practical efficacy of sorafenib monotherapy for advanced hepatocellular carcinoma patients in a Hepatitis B virus-endemic area

(2008) Ju Hyun Shim et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus–endemic area

(2007) Kyung Woo Park et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY